CERo Therapeutics Holdings, Inc. Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CEROW and buy or sell other stocks, ETFs, and their options commission-free!

About CEROW

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. 

CEO
Christopher B. Ehrlich, MBA
CEOChristopher B. Ehrlich, MBA
Employees
—
Employees—
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
Founded
Employees
—
Employees—

CEROW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
33.06K
Average volume33.06K
High today
$0.009
High today$0.009
Low today
$0.0012
Low today$0.0012
Open price
$0.009
Open price$0.009
Volume
20.37K
Volume20.37K
52 Week high
$0.0623
52 Week high$0.0623
52 Week low
$0.0011
52 Week low$0.0011

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.